- 01Glucose tells you whether; antibodies tell you which, and when
Glucose and A1C confirm diabetes only once it has arrived. Islet autoantibodies (GAD65, IA-2, ZnT8, insulin) and C-peptide answer whether it is type 1, and the antibodies can flag type 1 in stages 1 and 2 while glucose is still normal: about 70% of people with two or more reach clinical diabetes within 10 years 1. An A1C of 9% sits well inside the diabetes range and says nothing about the type, which is how adults with type 1 end up treated as type 2 2.
Type 1 diabetes starts quietly, often years before anyone notices thirst or weight loss, as the immune system works through the insulin-making cells of the pancreas. By the time symptoms appear, most of those cells are gone, and without insulin the body burns fat for fuel and makes acids called ketones that can turn into an emergency within days. Over 2 million Americans live with type 1, about 314,000 of them children and teens, out of roughly 40 million Americans with any kind of diabetes, according to the American Diabetes Association's summary of the CDC's National Diabetes Statistics Report 16. This guide covers the stages, the symptoms, the blood tests that separate type 1 from type 2, treatment, and the numbers to watch for life.
What type 1 diabetes is
Insulin is the hormone that lets glucose leave the blood and enter muscle, fat and liver cells. In type 1 diabetes, immune cells attack the beta cells, the insulin-making cells clustered in the islets of the pancreas. As beta cells die, insulin falls, and glucose piles up in the blood while the cells that need it go short. The American Diabetes Association (ADA) classifies type 1 by this absolute insulin deficiency; in type 2 diabetes the body still makes insulin but responds to it poorly 1. The full side-by-side is on our type 1 vs type 2 comparison, and the wider family of diabetes types is on diabetes.
Eating sugar does not cause type 1 diabetes, weight does not cause it, and no diet prevents it. People with type 1 come in every body size. Insulin resistance can sit on top of type 1, so an adult with type 1 can carry extra weight, which is one reason adults get misclassified.
How missing insulin turns into ketoacidosis
Type 1 starts years before symptoms: the three stages
Islet autoantibodies are antibodies the immune system makes against beta-cell proteins, and they show up in the blood long before glucose rises. Counting them alongside blood sugar lets doctors stage type 1 diabetes 1. The ADA puts the risk for someone in stage 1 at about 44% for clinical diabetes within 5 years and about 70% within 10 years, with lifetime risk approaching 100% 1.
| Stage | Islet autoantibodies | Blood sugar | Symptoms | What can be done |
|---|---|---|---|---|
| Stage 1 | Two or more | Normal | None | Rechecks of glucose or A1C on a schedule the care team sets, so stage 3 is caught before DKA; research trials |
| Stage 2 | Two or more | Abnormal but below the diabetes range (for example A1C 5.7% to 6.4%, the prediabetes range) | None | Teplizumab can delay stage 3 in people aged 8 and older 3 13; an endocrinologist decides whether it fits |
| Stage 3 | Usually present | In the diabetes range | Often thirst, frequent urination, weight loss | Insulin for life |
Teplizumab (brand name Tzield) is an antibody drug given by IV infusion once a day for 14 days. In the trial behind its approval, relatives of people with type 1 who were in stage 2 reached a clinical diagnosis after a median of 48.4 months on teplizumab and 24.4 months on placebo 3. The FDA approved it in November 2022 for people aged 8 and older in stage 2 13. It buys time, about two years at the median, and does not stop the disease.
Relatives of people with type 1 can get islet autoantibody screening through TrialNet, a research network, and the ADA standards support offering screening to people with a family history 1. If a screening test finds antibodies, ask the care team how often to recheck glucose or A1C, and learn the symptoms and the signs of DKA below so stage 3 is caught early. How antibody results are read in general is covered in autoimmune antibodies explained.
Symptoms of type 1 diabetes
The early signs come from glucose spilling into the urine. People often describe the four Ts: toilet (peeing often, including at night), thirsty, tired and thinner. Add hunger, blurred vision, thrush or genital itching, and new bedwetting in a child who was dry at night. Each of the main ones has its own page: always thirsty, frequent urination, unexplained weight loss and fatigue.
In children the symptoms usually build over days to a few weeks. Babies and toddlers cannot say they are thirsty, so the clues are very wet or frequent diapers, a diaper rash that will not clear (often thrush), irritability, weight loss, and vomiting that looks like a stomach bug; the youngest children are the most likely to be in DKA by the time type 1 is found. In adults the symptoms can creep in over months, and an adult who is thirsty and tired may be told they have type 2. In the US SEARCH for Diabetes in Youth study, about 4 in 10 young people diagnosed with type 1 in 2016 were already in DKA at or near diagnosis 12.
The blood tests that diagnose type 1, step by step
Diagnosing type 1 diabetes means answering two questions in order, and each needs its own tests. A glucose or A1C result answers only the first one: an A1C of 9% sits well inside the diabetes range and says nothing about which type. When someone is unwell, a third, urgent check runs alongside both: is this already DKA?
| Question | Test | The number that answers it |
|---|---|---|
| 1. Is it diabetes? | A1C, fasting glucose, 2-hour glucose on an oral glucose tolerance test (OGTT), random glucose | A1C 6.5% or more; fasting glucose 126 mg/dL (7.0 mmol/L) or more; 2-hour OGTT 200 mg/dL (11.1 mmol/L) or more; random glucose 200 mg/dL or more with symptoms. Unless symptoms and glucose are clear-cut, a doctor confirms with a second abnormal result 1 |
| 2. Is it type 1? | Islet autoantibodies (GAD65, IA-2, ZnT8, insulin); C-peptide | One or more positive antibodies makes type 1 likely; C-peptide below 200 pmol/L (0.6 ng/mL) fits type 1, above 600 pmol/L (1.8 ng/mL) makes it unlikely 2 |
| Alongside: is it an emergency? | Blood ketones (beta-hydroxybutyrate), urine ketones, blood pH, bicarbonate, anion gap | DKA: glucose 200 mg/dL or more (or known diabetes), blood ketones 3.0 mmol/L or more (or urine ketones 2+ or more), and pH below 7.3 or bicarbonate below 18 mmol/L 4 |
Three details change how these results read. A1C reflects about three months of glucose, so when type 1 comes on over a few weeks the A1C can still look modest while glucose is already very high; the ADA advises using glucose criteria in that situation 1. Which first test to trust in general is on A1C vs fasting glucose. Insulin autoantibodies count only before, or within about two weeks of, starting insulin, because injected insulin triggers antibodies of its own 2. A small share of people with type 1 test negative for all four antibodies, and C-peptide helps sort those cases 2.
C-peptide is a fragment cut from insulin as the pancreas makes it, and injected insulin contains none, so it measures the body's own insulin output even in someone who injects insulin. The joint consensus of the American Diabetes Association and the European Association for the Study of Diabetes (ADA/EASD) on type 1 in adults reads a random C-peptide against the cutoffs below and finds it most informative more than three years after diagnosis, once the honeymoon phase is over 2. What a low result means in detail is on the low C-peptide page.
Example random C-peptide in an adult diagnosed four years agopmol/L
The markers behind a type 1 diagnosis

A home glucose meter or a wellness blood panel cannot diagnose type 1 diabetes. A meter can show that glucose is high, which is a reason to see a doctor that day; the antibody and C-peptide tests, and the urgent ketone and pH checks, belong in a clinic or hospital.
Type 1 that starts in adulthood, and LADA
A large share of type 1 cases start in adults. A UK Biobank study that used genetic risk scores found that 42% of type 1 cases before age 60 were diagnosed between 31 and 60, and many of those adults were first treated as type 2 10. LADA (latent autoimmune diabetes in adults) is the slower adult form: antibodies are present, but the pancreas keeps making some insulin for months or years, so tablets can work for a while.
These clues suggest that a type 2 label may be wrong:
- Normal or low body weight, or fast weight loss around diagnosis
- Tablets that stop working within months to a few years
- Ketones in the blood or urine, or an episode of DKA
- Another autoimmune condition, such as thyroid disease or celiac disease
- A parent, sibling or child with type 1 or another autoimmune disease
- Diagnosis before about age 35
The ADA/EASD route for an adult in doubt is antibody testing first, starting with GAD65, then C-peptide if the antibodies are negative or the picture stays unclear 2. The type matters because a person with type 1 treated with tablets alone can slide into DKA. If you were told you have type 2 and several of these clues fit, ask your clinician: "Could this be type 1 or LADA? Can we check GAD65 antibodies and a C-peptide?"
Who gets type 1 diabetes
Type 1 runs in families, but only partly. The largest share of inherited risk sits in the HLA genes, which shape how the immune system tells the body's own tissue from invaders. Even so, most people diagnosed with type 1 have no parent or sibling with it. Having a parent with type 1 raises a child's odds, and the ADA's guidance gives these rough figures 15.
| Parent with type 1 | Child's approximate odds |
|---|---|
| Father | 1 in 17 |
| Mother, child born before she turned 25 | 1 in 25 |
| Mother, child born after she turned 25 | 1 in 100 |
Something in the environment seems to set off the immune attack in people who carry risk genes. Viral infections, particularly enteroviruses, and early-life factors are under study, and none is proven as a cause.
Type 1 often comes with other autoimmune conditions. Autoimmune thyroid disease affects 17 to 30% of people with type 1 and celiac disease about 1.6 to 16%, so the ADA's guidance for children advises a thyroid-stimulating hormone (TSH) test and celiac screening soon after diagnosis 9; adults are checked too, on a schedule the care team sets. Hashimoto's disease and celiac disease have their own guides; rarer ones include Addison's disease and pernicious anemia.
Treatment: insulin for life, and the technology around it
Insulin replaces what the beta cells no longer make, and everyone with stage 3 type 1 diabetes needs it. Most regimens copy a working pancreas with two parts: basal (background) insulin that covers the body's needs between meals and overnight, and bolus insulin for meals and to correct highs. The care team sets every dose, and doses change with food, activity, illness, growth and hormones.
| Way to deliver insulin | How it works | What it asks of the person |
|---|---|---|
| Pens (multiple daily injections) | Background insulin once or twice a day, plus mealtime insulin each time you eat | Several injections a day and a dose decision at every meal |
| Insulin pump | A small device delivers fast-acting insulin through a thin tube or a patch, a little at a time all day, with extra at meals | Changing the infusion set every few days; a blocked or dislodged set can lead to DKA within hours |
| Automated insulin delivery (hybrid closed loop) | A pump linked to a continuous glucose monitor; software raises or lowers insulin every few minutes | Entering carbs for meals and keeping both devices working |
Meal insulin is matched to carbohydrate. In the US, people count grams of carbohydrate from the nutrition label and use an insulin-to-carb ratio, set by their care team, that says how many grams one unit of insulin covers. As an illustration of the arithmetic only, a ratio of 1 unit per 10 grams applied to a meal with 60 grams of carbohydrate works out to 6 units; each person's actual ratio, and any correction for a high reading, is set by their care team. A continuous glucose monitor (CGM) is a small sensor worn on the skin that reads glucose every few minutes and alarms on highs and lows. The ADA/EASD consensus supports offering CGM and automated insulin delivery to adults with type 1 2.
There is no special type 1 diet. Sugar is not banned when it is counted and covered by insulin, and the same healthy eating advised for everyone applies. What changes is that carbohydrate has to be counted so the insulin dose matches it.
Beyond insulin, the options are narrow. Teplizumab delays stage 3 in people in stage 2 3. Lantidra (donislecel), donor islet cells infused into the liver, was approved by the FDA in June 2023 for adults who cannot reach their A1C goal because of repeated severe lows 14, and it requires immune-suppressing drugs for as long as the cells work. Islet cells grown from stem cells are in clinical trials. No supplement, diet or herbal product replaces insulin in type 1, and stopping insulin can lead to DKA within hours to a day or two.
The numbers to aim for, and the checks every year
Targets are set with a care team. The common starting points for adults come from the ADA/EASD consensus 2.
| Measure | Common goal for adults | What it tells you |
|---|---|---|
| A1C | Under 7% for many adults without frequent lows 2 | Average glucose over about three months |
| Time in range (CGM) | More than 70% of readings between 70 and 180 mg/dL 2 | How much of the day glucose stays in range |
| Time below 70 mg/dL | Under 4%, about 1 hour a day 2 | How often glucose runs low |
| Time below 54 mg/dL | Under 1%, about 15 minutes a day 2 | How often glucose runs dangerously low |
Children, older adults and pregnant people often have different goals, and pregnancy goals are tighter; pregnancy testing is covered in blood tests in pregnancy.
CalculatorGMI calculatorTurn your CGM average glucose into a GMI, the CGM's estimate of A1C.Work it out Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM [type 1 diabetes].DCCT Research Group, New England Journal of Medicine, 1993 5
IDDM, insulin-dependent diabetes mellitus, was the old name for type 1; retinopathy, nephropathy and neuropathy mean damage to the eyes, kidneys and nerves. Intensive therapy also roughly tripled severe low blood sugar in the trial 5, which is why goals are set with the care team. That damage builds for years without symptoms, and the checks below find it while treatment can still slow it.
| Test | How often | What it watches for |
|---|---|---|
| A1C | Every 3 months, or twice a year when stable at goal 6 | Average glucose; fructosamine can stand in when A1C is unreliable |
| Urine albumin-to-creatinine ratio | Yearly, starting 5 years after diagnosis 7 | Early kidney damage, before kidney filtering falls |
| eGFR (estimated glomerular filtration rate) | Yearly, starting 5 years after diagnosis 7 | Kidney filtering; see chronic kidney disease |
| Dilated eye exam | Within 5 years of diagnosis, then yearly, or every 1 to 2 years if no retinopathy is found 8 | Diabetic retinopathy |
| TSH | Soon after diagnosis, then every 1 to 2 years 9 | Autoimmune thyroid disease; TPO antibodies help confirm it |
| tTG-IgA (tissue transglutaminase antibody) with total IgA | In children, soon after diagnosis and again at about 2 and 5 years 9; at any age, when symptoms appear or as the care team advises | Celiac disease |
| Lipid panel, including LDL | At diagnosis and regularly after | Heart and blood vessel risk; see how to read your lipid panel |
The urine albumin-to-creatinine ratio appears on a urine report; see urine ACR. Kidney numbers in general are explained in kidney function explained.
The yearly blood and urine checks
Low blood sugar: the everyday risk
Injected insulin keeps lowering glucose whether or not the body needs it, so lows come with treatment. The ADA grades them: level 1 is below 70 mg/dL (3.9 mmol/L), level 2 is below 54 mg/dL (3.0 mmol/L), and level 3 is any low where the person needs someone else's help 6. Signs include shaking, sweating, a fast heartbeat, hunger, irritability and confusion; a level 3 low can bring seizures or passing out. Causes and signs in more depth are on hypoglycemia.
Alcohol and exercise both raise the risk of a low hours later, often overnight, because the liver releases less glucose after drinking and muscles keep pulling glucose in after a workout. The people someone with type 1 lives or works with should know the signs of a low and where the glucagon is kept.
CalculatorGlucose converterMeter or report in mmol/L? Convert it to mg/dL and back.Work it out Sick days, ketones and exercise
Illness raises stress hormones, which push glucose up and make ketones more likely even when someone is barely eating. Sick-day plans tell people with type 1 not to stop background insulin when ill, because without it ketones build fast, and to check ketones when glucose stays above about 240 to 250 mg/dL (13.3 to 13.9 mmol/L), or whatever level the plan sets, or with any vomiting. The care team's plan sets the exact numbers; the bands below are typical plan bands, not diagnostic cutoffs, and only the top one is the DKA threshold 4.
| Blood ketones (mmol/L) | What it usually means | What to do |
|---|---|---|
| Below 0.6 | Normal | Keep following the usual plan |
| 0.6 to 1.4 | Ketones rising | Follow the sick-day plan from the care team and recheck |
| 1.5 to 2.9 | High risk of DKA | Call the care team now; if you cannot reach them quickly, or there is vomiting, belly pain, fast or deep breathing, or drowsiness, go to the emergency department |
| 3.0 or more | Likely DKA 4 | Emergency: call 911 or go to the emergency department |
Vomiting with ketones, or vomiting that stops you keeping fluids down, needs urgent care: call the care team right away, and go to the emergency department or call 911 if you cannot reach them, if vomiting continues, or if there is belly pain, deep or fast breathing, or drowsiness. Urine ketone strips show a color rather than a number and lag behind the blood; a urine result of 2+ or more counts toward the DKA criteria 4. What the strip measures is on urine ketones.
Exercise usually lowers glucose during a session and for up to a day after, while hard sprints or competition can push it up briefly through adrenaline. High readings before breakfast have their own cause, explained in the dawn phenomenon. For how glucose, A1C and insulin fit together across every type of diabetes, see blood sugar explained.
Citations
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S27-S49
- Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2021;44(11):2589-2625
- Herold KC, Bundy BN, Long SA, et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 2019;381(7):603-613
- Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care 2024;47(8):1257-1275
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-986
- American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S128-S145
- American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S239-S251
- American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S252-S265
- American Diabetes Association Professional Practice Committee. 14. Children and adolescents: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S283-S305
- Thomas NJ, Jones SE, Weedon MN, et al. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol 2018;6(2):122-129
- Rawshani A, Sattar N, Franzen S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018;392(10146):477-486
- Jensen ET, Stafford JM, Saydah S, et al. Increase in prevalence of diabetic ketoacidosis at diagnosis among youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study. Diabetes Care 2021;44(7):1573-1578
- US Food and Drug Administration. TZIELD (teplizumab-mzwv) injection, prescribing information. Initial US approval 2022
- US Food and Drug Administration. FDA approves first cellular therapy to treat patients with type 1 diabetes. News release, 28 June 2023
- American Diabetes Association. Genetics of diabetes
- American Diabetes Association. Statistics about diabetes (from the CDC National Diabetes Statistics Report, 2023 data)
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.




